| Inflammatory breast cancer | Locally advanced breast cancer | Metastatic breast cancer | Non-T4 breast cancer | ||||
---|---|---|---|---|---|---|---|---|
 | Positiveb | Not positiveb | Positive | Not positive | Positive | Not positive | Positive | Not positive |
Overall mortality | Â | Â | Â | Â | Â | Â | Â | Â |
   Number of events | 400 | 280 | 239 | 131 | 648 | 347 | 4,128 | 1,397 |
   Number at risk | 703 | 477 | 484 | 255 | 942 | 506 | 34,754 | 9,575 |
   Unadjusted HR (95% CI) | 1 (ref) | 0.99 (0.85 to 1.15) | 1 (ref) | 1.01 (0.82 to 1.26) | 1 (ref) | 0.99 (0.87 to 1.12) | 1 (ref) | 1.19 (1.12 to 1.27) |
   Adjusted HR (95% CI)c | 1 (ref) | 0.87 (0.75 to 1.02) | 1 (ref) | 1.00 (0.81 to 1.24) | 1 (ref) | 0.88 (0.77 to 1.01) | 1 (ref) | 1.05 (0.99 to 1.12) |
Breast cancer-specific mortality | Â | Â | Â | Â | Â | Â | Â | Â |
   Number of events | 282 | 193 | 132 | 78 | 450 | 266 | 1,185 | 556 |
   Number at risk | 703 | 477 | 484 | 255 | 942 | 506 | 34,754 | 9,575 |
   Unadjusted HR (95% CI) | 1 (ref) | 0.98 (0.81 to 1.17) | 1 (ref) | 1.11 (0.84 to 1.47) | 1 (ref) | 1.09 (0.94 to 1.27) | 1 (ref) | 1.68 (1.52 to 1.86) |
   Adjusted HR (95% CI)c | 1 (ref) | 0.82 (0.68 to 0.99) | 1 (ref) | 0.96 (0.72 to 1.28) | 1 (ref) | 0.95 (0.82 to 1.11) | 1 (ref) | 1.16 (1.05 to 1.28) |